A case of M184V mutant human immunodeficiency virus in a patient using daily pre-exposure prophylaxis

被引：0

作者：

Jewsbury, Sally ^{[1
]}

Ward, Chris ^{[1
]}

机构：

[1] Cent Manchester NHS Fdn Trust, Northern Contracept Sexual Hlth & HIV Serv, 280 Upper Brook St, Manchester M13 0FH, Lancs, England

来源：

INTERNATIONAL JOURNAL OF STD & AIDS | 2020年 / 31卷 / 01期

关键词：

Prevention; sexual intercourse; human immunodeficiency virus; viral disease; sexual behaviour; TRANSMITTED DRUG-RESISTANCE; HIV; MEN;

D O I：

10.1177/0956462419879620

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

This study presents a case report of a 31-year-old gay man who acquired human immunodeficiency virus while using daily emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF) pre-exposure prophylaxis (PrEP). He had an M184V nucleoside reverse-transcriptase inhibitor mutation at diagnosis. Either he acquired a pre-existing M184V mutation or he acquired a wild-type virus but then suboptimal use of FTC/TDF led to the development of resistance. For PrEP to be safely managed and seroconvertors to be identified quickly, PrEP should be commissioned by the NHS and managed within sexual health clinics. Notwithstanding the current provision of PrEP, those accessing it must be reminded about the importance of regular testing and optimal adherence.

引用

页码：85 / 87

页数：3

共 9 条

[1] Antiretroviral Treatment, Preexposure Prophylaxis, and Drug Resistance in Sub-Saharan Africa: A Consensus Among Mathematical Models [J].

Abbas, Ume L. ;

Glaubius, Robert ;

Hood, Gregory ;

Mellors, John W. .

JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (01) :164-166

[2] Factors Influencing the Emergence and Spread of HIV Drug Resistance Arising from Rollout of Antiretroviral Pre-Exposure Prophylaxis (PrEP) [J].

Abbas, Ume L. ;

Hood, Gregory ;

Wetzel, Arthur W. ;

Mellors, John W. .

PLOS ONE, 2011, 6 (04)

[3] Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study [J].

Grant, Robert M. ;

Anderson, Peter L. ;

McMahan, Vanessa ;

Liu, Albert ;

Amico, K. Rivet ;

Mehrotra, Megha ;

Hosek, Sybil ;

Mosquera, Carlos ;

Casapia, Martin ;

Montoya, Orlando ;

Buchbinder, Susan ;

Veloso, Valdilea G. ;

Mayer, Kenneth ;

Chariyalertsak, Suwat ;

Bekker, Linda-Gail ;

Kallas, Esper G. ;

Schechter, Mauro ;

Guanira, Juan ;

Bushman, Lane ;

Burns, David N. ;

Rooney, James F. ;

Glidden, David V. .

LANCET INFECTIOUS DISEASES, 2014, 14 (09) :820-829

[4] Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial [J].

McCormack, Sheena ;

Dunn, David T. ;

Desai, Monica ;

Dolling, David I. ;

Gafos, Mitzy ;

Gilson, Richard ;

Sullivan, Ann K. ;

Clarke, Amanda ;

Reeves, Iain ;

Schembri, Gabriel ;

Mackie, Nicola ;

Bowman, Christine ;

Lacey, Charles J. ;

Apea, Vanessa ;

Brady, Michael ;

Fox, Julie ;

Taylor, Stephen ;

Antonucci, Simone ;

Khoo, Saye H. ;

Rooney, James ;

Nardone, Anthony ;

Fisher, Martin ;

McOwan, Alan ;

Phillips, Andrew N. ;

Johnson, Anne M. ;

Gazzard, Brian ;

Gill, Owen N. .

LANCET, 2016, 387 (10013) :53-60

[5] On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection [J].

Molina, J. -M. ;

Capitant, C. ;

Spire, B. ;

Pialoux, G. ;

Cotte, L. ;

Charreau, I. ;

Tremblay, C. ;

Le Gall, J. -M. ;

Cua, E. ;

Pasquet, A. ;

Raffi, F. ;

Pintado, C. ;

Chidiac, C. ;

Chas, J. ;

Charbonneau, P. ;

Delaugerre, C. ;

Suzan-Monti, M. ;

Loze, B. ;

Fonsart, J. ;

Peytavin, G. ;

Cheret, A. ;

Timsit, J. ;

Girard, G. ;

Lorente, N. ;

Preau, M. ;

Rooney, J. F. ;

Wainberg, M. A. ;

Thompson, D. ;

Rozenbaum, W. ;

Dore, V. ;

Marchand, L. ;

Simon, M. -C. ;

Etien, N. ;

Aboulker, J. -P. ;

Meyer, L. ;

Delfraissy, J. -F. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (23) :2237-2246

[6] Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis? [J].

Parikh, Urvi M. ;

Mellors, John W. .

CURRENT OPINION IN HIV AND AIDS, 2016, 11 (01) :49-55

[7]

Public Health England, 2018, HLTH PROT REP ADV AC, V13, P2

[8] HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis [J].

Supervie, Virginie ;

Garcia-Lerma, J. Gerardo ;

Heneine, Walid ;

Blower, Sally .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (27) :12381-12386

[9] Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom [J].

Tostevin, A. ;

White, E. ;

Dunn, D. ;

Croxford, S. ;

Delpech, V. ;

Williams, I. ;

Asboe, D. ;

Pozniak, A. ;

Churchill, D. ;

Geretti, A. M. ;

Pillay, D. ;

Sabin, C. ;

Leigh-Brown, A. ;

Smit, E. .

HIV MEDICINE, 2017, 18 (03) :204-213

← 1 →